Loading clinical trials...
Loading clinical trials...
An Open-label Uncontrolled Study to Assess the Safety and Immunogenicity of the Inactivated Adsorbed Vaccine Against COVID-19 (Coronavac) in Individuals Over 18 Years of Age During 24 Months of Follow-up
Conditions
Interventions
Adsorbed COVID-19 (inactivated) Vaccine
Locations
2
Brazil
Hospital Gloria D'Or - Hospitais Integrados da Gavea S/A
Rio de Janeiro, Brazil
D'Or Institute for Research and Education
Rio de Janeiro, Brazil
Start Date
February 19, 2021
Primary Completion Date
September 1, 2021
Completion Date
June 1, 2023
Last Updated
July 9, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
D'Or Institute for Research and Education
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions